Press "Enter" to skip to content

Swiss drugmaker Roche ups outlook as sales growth offsets price hit

Drugs division chief Bill Anderson said Roche’s drug revenue is soaring even as it honours a price-freeze pledge it made last year after Trump took to the phone and Twitter to urge companies to back off price hikes.

Also Read:   Study shows PICS as bioequivalent to Abraxane to treat breast cancer: SPARC